Prenatal methadone exposure is associated with altered neonatal brain development

Area of Science:

• Neuroscience
• Developmental Pediatrics
• Radiology

Background:

• Methadone is a common treatment for opioid use disorder during pregnancy.
• Prenatal exposure to methadone may negatively impact infant neurodevelopment.
• Understanding the effects of prenatal methadone on brain structure is crucial.

Purpose of the Study:

• To investigate the hypothesis that prenatal methadone exposure alters newborn brain development.
• To compare white matter microstructural integrity between methadone-exposed and non-exposed neonates.
• To assess the relationship between prenatal methadone exposure, head circumference, and brain development.

Main Methods:

• Diffusion MRI was performed on 20 methadone-exposed and 20 control neonates.
• Tract-based Spatial Statistics (TBSS) was used for voxel-wise analysis of fractional anisotropy (FA).
• Statistical comparisons were adjusted for gestational age at MRI and head circumference z-scores.

Main Results:

• Methadone-exposed neonates showed decreased FA in key white matter tracts, including the centrum semiovale, inferior longitudinal fasciculi (ILF), and internal/external capsules.
• Median FA was 12% lower in the methadone-exposed group.
• Reduced FA persisted in specific tracts even after adjusting for head circumference, suggesting an effect independent of head growth.

Conclusions:

• Prenatal methadone exposure is associated with significant white matter microstructural alterations detectable at birth.
• These brain changes appear independent of head growth, though polydrug use was common in the exposed group.
• Further research is needed to optimize management of opioid use disorder in pregnancy and evaluate long-term neurodevelopmental outcomes.